Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives (ProNounCE)
Primary Purpose
Wound Infection, Surgical Site Infection, Surgical Wound
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Wound dressings: Conservative dressings
Wound dressings: Prevena dressings
Wound dressings: ciVAC dressings
Sponsored by
About this trial
This is an interventional prevention trial for Wound Infection focused on measuring Surgical Site infections, Negative Pressure Wound Therapy, Contaminated abdominal wounds, Closed incision abdominal wound, Prophylactic therapy
Eligibility Criteria
Inclusion Criteria:
- Emergency, trauma or elective contaminated abdominal operations within general surgery and/or colorectal surgery
- Abdominal wounds closed at time of operation and expected to heal by primary intention
- Patients who have the capacity to consent
- To include complex abdominal wounds with existing infection where wounds have been closed and expected to heal by primary intention
- To including graft or flap sites as part of general surgical procedure
- Patients who are able to complete questionnaires post operatively, either alone or with assistance
Exclusion Criteria:
- Wounds where an appropriate seal cannot be obtained
- Wounds left open and expected to heal by secondary intention
- Patients known to have allergy or sensitivity to dressings being used
- Patients who lack the capacity to consent
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
Conservative dressings
Prevena dressing
ciVAC dressing
Arm Description
Use of simple dressings on wound post operatively - to be placed at end of operation
Use of Prevena(KCI) dressing on wound post operatively - to be placed at end of operation
Use of closed incision VAC (vacuum assisted closure) dressing on wound post operatively - to be placed at end of operation
Outcomes
Primary Outcome Measures
Surgical Site Infection
The occurrence of surgical site infections at the post-operative wound and timeframe of occurrence
Secondary Outcome Measures
Wound assessments - clinical assessment of presence of wound complication and healing
Independent blind assessment of wounds at day 7 post operatively, on discharge and at outpatient follow up, via wound photographs taken, and correlation with assessment by clinical team
Length of stay
Length of stay post-operatively
Number of additional interventions received by participants due to development of a Surgical Site Infection
Need for intervention or treatment for surgical site infection (antibiotics, opening up of wound at bedside, operative or radiological intervention)
Microscopy, culture and sensitivity results from swabs of any Surgical Site Infections
Culture results if SSI post-operative (including sensitivities)
Post operative complications - other
Occurrence of other post-operative complications
Number of adverse reactions to treatments for Surgical Site Infections
Adverse reactions to antibiotics given or to dressings use
Wound dressings - use of
Time to discontinuation of dressings, type and number of dressings used
Ninety day mortality rate
Mortality within 90 days
Ninety day readmission rate
Rate of readmission within 90 days
Cause of death
Cause of death for any mortalities within 90 days
Quality of life measures: EuroQol 5 Dimensions 5 Levels (EQ5D5L) questionnaire
Generic quality of life outcome measures using EQ5D5L questionnaire assessed at day 7 post operatively, on discharge and at outpatient follow up; individualised questions, no formal scale
Quality of life measures: Wound Quality of Life questionnaires
Wound specific quality of life outcome measures using Wound Quality of Life questionnaire assessed at day 7 post operatively, on discharge and at outpatient follow up; scales - not at all/a little/moderately/quite a lot/very much
Quality of life and economic measures: Economic assessment questionnaire
Assessment of economic impact of wound using single Economic questionnaire to be assessed at day 40; individualised questions that will be assessed, no formal scale
Long term follow up - Hernia occurrence
Development of incisional hernia
Full Information
NCT ID
NCT04110353
First Posted
September 20, 2019
Last Updated
September 26, 2023
Sponsor
Imperial College London
1. Study Identification
Unique Protocol Identification Number
NCT04110353
Brief Title
Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives
Acronym
ProNounCE
Official Title
Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives: A Multi-centre Randomised Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Withdrawn
Why Stopped
Lack of funding
Study Start Date
June 2020 (Anticipated)
Primary Completion Date
June 2021 (Anticipated)
Study Completion Date
June 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Imperial College London
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study evaluates whether specialist negative pressure dressings reduce the risk of wound infections after operations when compared to conservative dressings, and if one negative pressure dressings works better than another. The study will look at patients who have had an open operation on their bowel and the wound closed at the end of the operation.
Detailed Description
Surgical site infections (SSI) can affect up 41% of patients post-operatively. They are associated with significant healthcare and patient costs, and increased patient morbidity and mortality.
Specialist post operative dressings with negative pressure wound therapy are available, and the WHO do recommended for use in high risk wounds, taking resources into account. However no further recommendations are available.
This study will explore the rate of post-operative wound infections in adult patients undergoing open abdominal surgery on the bowel, and compare the rate of wound infections in these patients in relation to three different dressing types used after their operation. The study aims to determine if any of the dressings used within the study are associated with lower post-operative wound infection rates, and compare the overall costs of using each dressing type, including both direct healthcare costs and societal costs. Finally, it will evaluate participant's quality of life outcomes after open abdominal surgery, specifically relating to their wound.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Infection, Surgical Site Infection, Surgical Wound, Surgical Incision
Keywords
Surgical Site infections, Negative Pressure Wound Therapy, Contaminated abdominal wounds, Closed incision abdominal wound, Prophylactic therapy
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
Stepped wedge design with randomisation at the level of the Hospitals not individual patients
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Conservative dressings
Arm Type
Active Comparator
Arm Description
Use of simple dressings on wound post operatively - to be placed at end of operation
Arm Title
Prevena dressing
Arm Type
Active Comparator
Arm Description
Use of Prevena(KCI) dressing on wound post operatively - to be placed at end of operation
Arm Title
ciVAC dressing
Arm Type
Active Comparator
Arm Description
Use of closed incision VAC (vacuum assisted closure) dressing on wound post operatively - to be placed at end of operation
Intervention Type
Other
Intervention Name(s)
Wound dressings: Conservative dressings
Intervention Description
Conservative dressings to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.
Intervention Type
Other
Intervention Name(s)
Wound dressings: Prevena dressings
Intervention Description
Prevena dressing to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.
Intervention Type
Other
Intervention Name(s)
Wound dressings: ciVAC dressings
Intervention Description
Closed incision VAC dressings to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.
Primary Outcome Measure Information:
Title
Surgical Site Infection
Description
The occurrence of surgical site infections at the post-operative wound and timeframe of occurrence
Time Frame
Up to day 90
Secondary Outcome Measure Information:
Title
Wound assessments - clinical assessment of presence of wound complication and healing
Description
Independent blind assessment of wounds at day 7 post operatively, on discharge and at outpatient follow up, via wound photographs taken, and correlation with assessment by clinical team
Time Frame
At day 7 (on removal of dressing), up to day 30 (on discharge), day 40 (at outpatient follow up)
Title
Length of stay
Description
Length of stay post-operatively
Time Frame
Up to 90 days
Title
Number of additional interventions received by participants due to development of a Surgical Site Infection
Description
Need for intervention or treatment for surgical site infection (antibiotics, opening up of wound at bedside, operative or radiological intervention)
Time Frame
Within 30 days
Title
Microscopy, culture and sensitivity results from swabs of any Surgical Site Infections
Description
Culture results if SSI post-operative (including sensitivities)
Time Frame
Within 30 days
Title
Post operative complications - other
Description
Occurrence of other post-operative complications
Time Frame
Within 30 days
Title
Number of adverse reactions to treatments for Surgical Site Infections
Description
Adverse reactions to antibiotics given or to dressings use
Time Frame
Within 30 days
Title
Wound dressings - use of
Description
Time to discontinuation of dressings, type and number of dressings used
Time Frame
Up to day 30-40
Title
Ninety day mortality rate
Description
Mortality within 90 days
Time Frame
Up to day 90
Title
Ninety day readmission rate
Description
Rate of readmission within 90 days
Time Frame
Up to day 90
Title
Cause of death
Description
Cause of death for any mortalities within 90 days
Time Frame
Up to day 90
Title
Quality of life measures: EuroQol 5 Dimensions 5 Levels (EQ5D5L) questionnaire
Description
Generic quality of life outcome measures using EQ5D5L questionnaire assessed at day 7 post operatively, on discharge and at outpatient follow up; individualised questions, no formal scale
Time Frame
At day 7 (on removal of dressing), up to day 30 (on discharge), day 40 (at outpatient follow up)
Title
Quality of life measures: Wound Quality of Life questionnaires
Description
Wound specific quality of life outcome measures using Wound Quality of Life questionnaire assessed at day 7 post operatively, on discharge and at outpatient follow up; scales - not at all/a little/moderately/quite a lot/very much
Time Frame
At day 7 (on removal of dressing), up to day 30 (on discharge), day 40 (at outpatient follow up)
Title
Quality of life and economic measures: Economic assessment questionnaire
Description
Assessment of economic impact of wound using single Economic questionnaire to be assessed at day 40; individualised questions that will be assessed, no formal scale
Time Frame
At day 40
Title
Long term follow up - Hernia occurrence
Description
Development of incisional hernia
Time Frame
At 1, 3 and 5 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Emergency, trauma or elective contaminated abdominal operations within general surgery and/or colorectal surgery
Abdominal wounds closed at time of operation and expected to heal by primary intention
Patients who have the capacity to consent
To include complex abdominal wounds with existing infection where wounds have been closed and expected to heal by primary intention
To including graft or flap sites as part of general surgical procedure
Patients who are able to complete questionnaires post operatively, either alone or with assistance
Exclusion Criteria:
Wounds where an appropriate seal cannot be obtained
Wounds left open and expected to heal by secondary intention
Patients known to have allergy or sensitivity to dressings being used
Patients who lack the capacity to consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christopher Peters
Organizational Affiliation
Imperial College London
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Carolynne Vaizey
Organizational Affiliation
St Mark's Hospital and Academic Institute
Official's Role
Study Chair
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives
We'll reach out to this number within 24 hrs